656
Participants
Start Date
September 16, 2021
Primary Completion Date
July 25, 2023
Study Completion Date
July 25, 2024
Proximity-incentive strategy based on vaginal self-sampling for women 50 to 65 years who do not participate to cervical cancer screening
"* Direct offer of a vaginal self-sampling kit with information to perform at home and send back to the laboratory for HR-HPV testing~* The psychosocial determinants involved in decision-making process and compliance to cervical cancer screening will be collected from open questionnaires and by semi-directive phone interviews~* Control ; Receive reminder to send the self-sample to the laboratory : After 3 and 6 months without return, women receive a remind letter to send the vaginal self-sample to the laboratory. We call return the receipt of the vaginal self-sample at the laboratory.~* Control ; Receive reminder to perform cervical smear in case of positive HR-HPV test : In case of a positive HR-HPV test, women are asked to perform a control cervical smear. After 3, 6 months and 12 months without return, women and their health-care professional will receive a remind letter or a call to perform a cervical smear for control. We call return the performance of a pap smear."
Arnaud de Villeneuve Hospital, clinical trials Department, Montpellier
Mammobile Hérault, Montpellier
Paul Valérie University Montpellier
UNKNOWN
Regional Center for Cancer Screening (CRCDC) - Region of Occitanie - Department of Herault
UNKNOWN
Regional Center for Cancer Screening (CRCDC) - Region of Occitanie - Department of Aude
UNKNOWN
Association for Breast Cancer Screening - Department of Herault (AMHDCS)
UNKNOWN
University Hospital, Montpellier
OTHER